Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-10-22
2010-11-02
Landsman, Robert (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S300000, C530S308000
Reexamination Certificate
active
07825090
ABSTRACT:
A novel combination of ghrelin and unacylated ghrelin is described herein. Methods of administering and uses of this combination to alter an insulin-associated parameter are also described. Compositions and packages containing ghrelin and/or one of its analogs and nonacylated ghrelin and/or one of its analogs as well as the uses of such compositions in providing therapeutic benefit to human patients diagnosed with for example insulin resistance, diabetes and obesity are described.
REFERENCES:
patent: 4554101 (1985-11-01), Hopp
patent: 7485620 (2009-02-01), Ghigo et al.
patent: 2470235 (2003-06-01), None
patent: 2471879 (2003-11-01), None
patent: WO-01/56592 (2001-08-01), None
patent: 01/87335 (2001-11-01), None
patent: WO-01/92292 (2001-12-01), None
patent: WO-02/060472 (2002-08-01), None
patent: 03/051389 (2003-06-01), None
Ariyasu, H. et al., “Stomach is a Major Source of Circulating Ghrelin, and Feeding State Determines Plasma Ghrelin-Like Immunoreactivity Levels in Humans”, The Journal of Clinical Endocrinology & Metabolism, vol. 86, No. 10 (2001) pp. 4753-4758.
Bednarek, M. A. et al., “Structure—Function Studies on the New Growth Hormone-Releasing Peptide Ghrelin: Minimal Sequence of Ghrelin Necessary for Activation of Growth Hormone Secretagogue Receptor 1a”, J. Med. Chem, vol. 43 (2000) pp. 4370-4376.
Caixas, A. et al., “Insulin, unlike Food Intake, does not Suppress Ghrelin in Human Subjects”, The Journal of Clinical Endocrinology & Metabolism, vol. 87, No. 4 (2002) pp. 1902-1906.
Chapman, I. et al. “Enhancement of Pulsatile Growth Hormone Secretion by Continuous Infusion of a Growth Hormone-Releasing Peptide Mimetic, L-692,429, in Older Adults—A Clinical Research Center Study.” Journal of Clinical Endocrinology and Metabolism, vol. 81, No. 8 (1996) pp. 2874-2880.
Chapman, I. et al., “Oral Administration of Growth Hormone (GH) Releasing Peptide-Mimetic MK-677 Stimulates the GH/Insulin-Like Growth Factor-I Axis in Selected GH-Deficient Adults”, Journal of Clinical Endocrinology and Metabolism, vol. 82, No. 10 (1997) pp. 3455-3463.
Cummings, D. E. et al., “A Preprandial Rise in Plasma Ghrelin Levels Suggests a Role in Meal Initiation in Humans”, Diabetes, vol. 50 (Aug. 2001) pp. 1714-1719.
Date, Y. et a., “Ghrelin Acts in the Central Nervous System to Stimulate Gastric Acid Secretion”, Biochemical and Biophysical Research Communications, vol. 280 (2001) pp. 904-907.
Date, Y. et al., “Ghrelin is Present in Pancratic α-Cells of Humans and Rats and Stimulates Insulin Secretion”, Diabetes, vol. 51 (Jan. 2002) pp. 124-129.
Date, Y. et al., “Ghrelin, a Novel Growth Hormone-Released Acylated Peptide, Is Synthesized in a Distinct Endocrine Cell Type in the Gastrointestinal Tracts of Rats and Humans.” Endocrinology, vol. 141, No. 11 (2000) pp. 4255-4261.
European Office Action, corresponding to European Application No. 02787266.2, Oct. 7, 2008.
Furuse, M. et al., “Intracerebroventricular injection of ghrelin and growth hormone releasing factor inhibits food intake in neonatal chicks”, Neuroscience Letters, Vo. 301 (2001) pp. 123-126.
Gualillo et al. “Ghrelin, A Novel Placental-Derived Hormone”, Endocrinology, vol. 142, No. 2, (2001) pp. 788-794.
Hattori et al. “GH, GH Receptor, GH Secretagogue Receptor, and Ghrelin Expression in Human T Cells, B Cells, and Neutrophils.” The Journal of Clinical Endocrinology and Metabolism, vol. 86, No. 9 (2001) pp. 4284-4291.
Horvath, T. L. et al., “Minireview: Ghrelin and the Regulation of Energy Balance—A hypothalamic Perspective”, Endocrinology, vol. 142, No. 10 (2001) pp. 4163-4169.
Inui, Akio, “Ghrelin: An orexigenic and Somatotrophic Signal from the Stomach”, Nature Reviews, vol. 2 (Aug. 2001) pp. 1-10.
Kamegai, J. et al., “Central Effect of Ghrelin, an Endogenous Growth Hormone Secretagogue, on Hypothalamic Peptide Gene Expression”, Endocrinology, vol. 141, No. 12, 2000, pp. 4797-4800.
Kamegai, J. et al., “Chronic Central Infusion of Ghrelin Increases Hypothalamic Neuropeptide Y and Agouti-Related Protein mRNA Levels and Body Weight in Rats”, Diabetes, vol. 40 (Nov. 2001) pp. 2438-2443.
Kojima et al. “Ghrelin is a growth-hormone-releasing acylated peptide from stomach”Nature, vol. 402, Dec. 9, 1999. (pp. 656-660).
Korbonits et al. “The presence of ghrelin in normal and adenomatous human pituitary,” Department of Endocrinology, St. Bartholomew's Hospital, London, UK and Department of Biochemistry, National Cardiovascular Center Institute, Fujishirodau, Suita, Osaka Japan (11 pgs), 2009.
Lucid!, P. et al., “Ghrelin is not Necessary for Adequate Hormonal Counterregulation of Insulin-Induced Hypoglycemia”, Diabetes, vol. 51 (Oct. 2002) pp. 2911-2914.
Masuda, Y. et al., “Ghrelin Stimulates Gastric Acid Secretion and Motility in Rats”, Biochemical and Biophysical Research Communications, vol. 276 (2000) pp. 905-908.
Matsumoto, M. et al., “Structure-Activity Relationship of Ghrelin: Pharmacological Study of Ghrelin Peptides”, Biochemical and Biophysical Research Communications, vol. 287 (2001), pp. 142-146.
Mori, K. et al., “Kidney produces a novel acylated peptide, ghrelin”, FEBS Letters, vol. 486 (2000) pp. 213-216.
Muccioli, G. et al. “Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity,” European Journal of Pharmacology, vol. 440 (2002) pp. 235-254.
Muccioli, G. et al., “Binding of 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland”, J. Endocrinol. Invest., vol. 24 (2001) pp. RC7-RC9.
Muller, A. F. et al., “Blockade of the Growth Hormone (GH) Receptor Unmasks Rapid GH-Releasing Peptide-6-Mediated Tissue-Specific Insulin Resistance”, The Journal of Clinical Endocrinology & Metabolism, vol. 86, No. 2, 2001, pp. 590-593.
Nagaya, N. et al., “Hemodynamic and hormonal effects of human ghrelin in healthy volunteers”, Am J. Physiol Regulatory Integrative Comp. Physiol., vol. 280 (2001) pp. R1483-R1487.
Nakagawa, E. et al., “Hyperglycaemia suppresses the secretion of ghrelin, a novel growth-hormone-releasing peptide: responses to the intravenous and oral administration of glucose”, Clinical Science, vol. 103 (2002) pp. 325-328.
Okumura, H. et al., “Vasodilatory Effect of Ghrelin, an Endogenous Peptide from the Stomach”, Journal of Cadiovascular Pharmacology, vol. 39 (2002) pp. 779-783.
Pagotto, U. et al., “Plasma Ghrelin, Obesity, and the Polycystic Ovary Syndrome: Correlation with Insulin Resistance and Androgen Levels”, The Journal of Clinical Endocrinology & Metabolism, vol. 87, No. 12 (2002) pp. 5625-5629.
Saad, M. et al., “Insulin Regulates Plasma Ghrelin Concentration”, The Journal of Clinical Endocrinology & Metabolism, vol. 87, No. 8 (2002) pp. 3997-4000.
Svensson, J. et al., “Two-Month Treatment of Obese Subjects with the Oral Growth Hormone (GH) Secretagogue MK-677 Increases GH Secretion, Fat-Free Mass, and Energy Expenditure”, Journal of Clinical Endocrinology and Metabolism. vol. 83, No. 2 (1998) pp. 362-369.
Tanka, M. et al., “Testis-specific and developmentally induced expression of a ghrelin gene-deprived transcript that encodes a novel polypeptide in the mouse”, Biochimica et Biophysica Acta, vol. 1522 (2001) pp. 62-65.
Tena-Sempere, M. et al., “Novel Expression and Functional Role of Ghrelin in Rat Testis”, Endocrinology, vol. 143, No. 2, 2002, pp. 717-725.
Tolle, V. et al., “Ultradian Rhythmicity of Ghrelin Secretion in Relation with GH, Feeding Behavior, and Sleep-Wake Patterns in Rats”, Endocrinology, vol. 143, No. 4 (2002) pp. 1353-1361.
Tschop, M. et al., “Ghrelin induces adiposity in rodents”, Letters to Nature, vol. 407 (Oct. 19,
Ghigo Ezio
Van Der Lely Aart Jan
Alizé Pharma SAS
Chandra Gyan
Landsman Robert
Wilmer Cutler Pickering Hale and Dorr LLP
LandOfFree
Use of ghrelin and unacylated ghrelin compositions for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of ghrelin and unacylated ghrelin compositions for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of ghrelin and unacylated ghrelin compositions for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4203050